Overview

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether crushed EMBEDA capsules induce clinical opiate withdrawal signs and symptoms in opioid-dependent patients with chronic non-cancer pain who are stabilized on EMBEDA.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Analgesics, Opioid
Morphine
Naltrexone